Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M109187200 on December 10, 2001

J. Biol. Chem., Vol. 277, Issue 9, 7477-7482, March 1, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/9/7477    most recent
M109187200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by Takusagawa, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.
Right arrow Articles by Takusagawa, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of S-Adenosylhomocysteine Hydrolase by Acyclic Sugar Adenosine Analogue D-Eritadenine
CRYSTAL STRUCTURE OF S-ADENOSYLHOMOCYSTEINE HYDROLASE COMPLEXED WITH D-ERITADENINE*

Yafei HuangDagger , Junichi KomotoDagger , Yoshimi TakataDagger §, Douglas R. PowellDagger , Tomoharu Gomi§, Hirofumi Ogawa§, Motoji Fujioka§, and Fusao TakusagawaDagger

From the Dagger  Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045-7534 and the § Department of Biochemistry, Toyama Medical and Pharmaceutical University, Faculty of Medicine, Sugitani, Toyama 930-0194, Japan

D-Eritadenine (DEA) is a potent inhibitor (IC50 = 7 nM) of S-adenosyl-L-homocysteine hydrolase (AdoHcyase). Unlike cyclic sugar Ado analogue inhibitors, including mechanism-based inhibitors, DEA is an acyclic sugar Ado analogue, and the C2' and C3' have opposite chirality to those of the cyclic sugar Ado inhibitors. Crystal structures of DEA alone and in complex with AdoHcyase have been determined to elucidate the DEA binding scheme to AdoHcyase. The DEA-complexed structure has been analyzed by comparing it with two structures of AdoHcyase complexed with cyclic sugar Ado analogues. The DEA-complexed structure has a closed conformation, and the DEA is located near the bound NAD+. However, a UV absorption measurement shows that DEA is not oxidized by the bound NAD+, indicating that the open-closed conformational change of AdoHcyase is due to the substrate/inhibitor binding, not the oxidation state of the bound NAD. The adenine ring of DEA is recognized by four essential hydrogen bonds as observed in the cyclic sugar Ado complexes. The hydrogen bond network around the acyclic sugar moiety indicates that DEA is more tightly connected to the protein than the cyclic sugar Ado analogues. The C3'-H of DEA is pointed toward C4 of the bound NAD+ (C3'···C4 = 3.7 Å), suggesting some interaction between DEA and NAD+. By placing DEA into the active site of the open structure, the major forces to stabilize the closed conformation of AdoHcyase are identified as the hydrogen bonds between the backbone of His-352 and the adenine ring, and the C3'-H···C4 interaction. DEA has been believed to be an inactivator of AdoHcyase, but this study indicates that DEA is a reversible inhibitor. On the basis of the complexed structure, selective inhibitors of AdoHcyase have been designed.


* The work carried out at the University of Kansas was supported by National Institutes of Health Grant GM37233.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates for the crystal structure of this protein are available in the Cambridge Crystallographic Data Center Database under CCDC accession number 171285.

The atomic coordinates and the structure factors (code 1K0U) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

To whom correspondence should be addressed: Dept. of Molecular Biosciences, 3004 Haworth Hall, University of Kansas, 1200 Sunnyside Ave., Lawrence, KS 66045-7534. Tel.: 785-864-4727; Fax: 785-864-5321; E-mail: x-raymain@ku.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Takata, T. Yamada, Y. Huang, J. Komoto, T. Gomi, H. Ogawa, M. Fujioka, and F. Takusagawa
Catalytic Mechanism of S-Adenosylhomocysteine Hydrolase. SITE-DIRECTED MUTAGENESIS OF ASP-130, LYS-185, ASP-189, AND ASN-190
J. Biol. Chem., June 14, 2002; 277(25): 22670 - 22676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement